Ballicules.com

Erythromycin

ERYTHROCIN

What it isMacrolide inhibiting the 50S ribosomal subunit; atypical infection, and used off-label as a prokinetic.

Why this oneIts motilin agonism makes it useful for gastroparesis, which no other antibiotic offers.

What limits itA strong CYP3A4 inhibitor and QT prolonger, so interactions are constant. GI upset limits the dose; tachyphylaxis develops in prokinetic use.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Susceptible infections (usual)Adults400 mg QID (q6h)400 mg QID (q6h)4 g/day
Susceptible infections (usual)Children30-50 mg/kg/day divided q6h30-50 mg/kg/day100 mg/kg/day (severe)
Streptococcal prophylaxis (rheumatic heart disease)Adults400 mg BID400 mg BID400 mg BID

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy No evidence of teratogenicity or reproductive harm in animal studies

Lactation Undefined

NO BOXED WARNINGS

Principal riskA strong CYP3A4 inhibitor; QT prolongation

Cost, est. cash$300–$2,500/month

Generic entry1990

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades3 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryC

Defining liabilityAllergy, gastrointestinal effects and agent-specific renal, hepatic, hematologic or interaction risks.

Mechanism of action: Erythromycin ballicule

Erythromycin ballicule: receptor binding, kinetics and half-life diagram

Open Erythromycin in the interactive console ↗

Memory aids: mascots and interaction avatars

Erythromycin E-MYCIN mascot mnemonic cartoon
“(Eryth) throw your mice in here”
macrolide ring
erythro = red
Erythromycin CYP3A4 inhibitor avatar
CYP3A4 inhibitor

Open Erythromycin in the interactive console ↗